ArticleBritish journal of cancer2011

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models.

K Dredge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.